Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Biochemistry and medicinal chemistry of the dengue virus protease

dc.contributor.authorNitsche, Christophen
dc.contributor.authorHolloway, Stevenen
dc.contributor.authorSchirmeister, Tanjaen
dc.contributor.authorKlein, Christian D.en
dc.date.accessioned2025-06-11T10:34:43Z
dc.date.available2025-06-11T10:34:43Z
dc.date.issued2014-11-26en
dc.description.abstractThe dengue virus contains a single-stranded RNA genome, which is replicated by the translation mechanisms of the host in conjunction with the viral RNA-dependent RNA polymerase. Replication of dengue virus requires the formation of virus-specific biomolecular machinery at the rough endoplasmatic reticulum that is known as the replication complex and consists of vesicular membrane structures. The protease of dengue virus is devoid of cysteine residues and therefore does not contain disulfide bonds. There are also no indications of essential posttranslational modifications. These properties make a heterologous expression of the protein in bacteria relatively straightforward. The first generation of dengue virus protease inhibitors was derived from the cleavage sites of the viral polyprotein. Peptidic compounds that combine these peptide-based inhibitors with highly reactive electrophiles can target the catalytically active serine and occupy all important recognition sites of the protease as confirmed by X-ray crystal structure analysis. Promising alternative to in vitro assays of dengue protease acitivity would be cell-based assays, in which the binding of inhibitors to the enzyme is studied under native conditions.en
dc.description.statusPeer-revieweden
dc.format.extent34en
dc.identifier.issn0009-2665en
dc.identifier.otherPubMed:25268322en
dc.identifier.otherORCID:/0000-0002-3704-2699/work/162948546en
dc.identifier.scopus84913573187en
dc.identifier.urihttp://www.scopus.com/inward/record.url?scp=84913573187&partnerID=8YFLogxKen
dc.identifier.urihttps://hdl.handle.net/1885/733758503
dc.language.isoenen
dc.sourceChemical Reviewsen
dc.titleBiochemistry and medicinal chemistry of the dengue virus proteaseen
dc.typeJournal articleen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage11381en
local.bibliographicCitation.startpage11348en
local.contributor.affiliationNitsche, Christoph; Medicinal Chemistryen
local.contributor.affiliationHolloway, Steven; Johannes Gutenberg University Mainzen
local.contributor.affiliationSchirmeister, Tanja; Johannes Gutenberg University Mainzen
local.contributor.affiliationKlein, Christian D.; Heidelberg University en
local.identifier.citationvolume114en
local.identifier.doi10.1021/cr500233qen
local.identifier.purec9866f16-c9dd-4d85-bc34-8c887e111befen
local.identifier.urlhttps://www.scopus.com/pages/publications/84913573187en
local.type.statusPublisheden

Downloads